[go: up one dir, main page]

SG10201505564VA - Combination pharmaceutical composition and methods of treating genitourinary system disorders - Google Patents

Combination pharmaceutical composition and methods of treating genitourinary system disorders

Info

Publication number
SG10201505564VA
SG10201505564VA SG10201505564VA SG10201505564VA SG10201505564VA SG 10201505564V A SG10201505564V A SG 10201505564VA SG 10201505564V A SG10201505564V A SG 10201505564VA SG 10201505564V A SG10201505564V A SG 10201505564VA SG 10201505564V A SG10201505564V A SG 10201505564VA
Authority
SG
Singapore
Prior art keywords
methods
pharmaceutical composition
system disorders
genitourinary system
combination pharmaceutical
Prior art date
Application number
SG10201505564VA
Inventor
Oleg Iliich Epshtein
Original Assignee
Oleg Iliich Epshtein
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from RU2010129294/15A external-priority patent/RU2542414C2/en
Priority claimed from RU2010129295/15A external-priority patent/RU2531049C2/en
Priority claimed from RU2011127053/15A external-priority patent/RU2565400C2/en
Application filed by Oleg Iliich Epshtein filed Critical Oleg Iliich Epshtein
Publication of SG10201505564VA publication Critical patent/SG10201505564VA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/303—Liver or Pancreas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A61K2039/507—Comprising a combination of two or more separate antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Microbiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Mycology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG10201505564VA 2010-07-15 2011-07-15 Combination pharmaceutical composition and methods of treating genitourinary system disorders SG10201505564VA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU2010129294/15A RU2542414C2 (en) 2010-07-15 2010-07-15 Medication for treating erectile dysfunctions and method of treating erectile dysfunctions
RU2010129295/15A RU2531049C2 (en) 2010-07-15 2010-07-15 Therapeutic agent for treating prostatic diseases and method of treating prostatic diseases
RU2011127053/15A RU2565400C2 (en) 2011-07-01 2011-07-01 Medication for treating genitourinary system diseases and method of treating genitourinary system diseases

Publications (1)

Publication Number Publication Date
SG10201505564VA true SG10201505564VA (en) 2015-09-29

Family

ID=44899158

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201505564VA SG10201505564VA (en) 2010-07-15 2011-07-15 Combination pharmaceutical composition and methods of treating genitourinary system disorders
SG2013002308A SG187036A1 (en) 2010-07-15 2011-07-15 Combination pharmaceutical composition and methods of treating genitourinary system disorders

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG2013002308A SG187036A1 (en) 2010-07-15 2011-07-15 Combination pharmaceutical composition and methods of treating genitourinary system disorders

Country Status (17)

Country Link
US (1) US20130064860A1 (en)
EP (1) EP2593483A2 (en)
JP (3) JP2013538791A (en)
CN (1) CN103282384A (en)
AU (1) AU2011278042B2 (en)
CA (1) CA2805094A1 (en)
DE (1) DE112011102350T5 (en)
EA (1) EA029860B1 (en)
ES (1) ES2425314R1 (en)
FR (1) FR2962655A1 (en)
GB (1) GB2495885B (en)
IT (1) ITTO20110631A1 (en)
MX (1) MX354187B (en)
MY (1) MY165267A (en)
NZ (1) NZ606775A (en)
SG (2) SG10201505564VA (en)
WO (1) WO2012007849A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2181297C2 (en) * 2000-06-20 2002-04-20 Эпштейн Олег Ильич Method of treatment of pathological syndrome and medicinal agent
UA76638C2 (en) 2002-08-02 2006-08-15 Oleh Illich Epshtein Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon
RU2309732C1 (en) * 2006-03-13 2007-11-10 Олег Ильич Эпштейн Pressed solid oral formulation of medicinal preparation and method for preparing solid oral formulation of medicinal preparation
EP2593474A2 (en) 2010-07-15 2013-05-22 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases
CZ2013105A3 (en) * 2010-07-15 2013-05-22 Iliich Epshtein@Oleg Method of increasing effect of antibody activated potentiated form
WO2012010970A2 (en) 2010-07-21 2012-01-26 Oleg Iliich Epshtein A method of treating attention deficit hyperactivity disorder
AU2011281247B2 (en) 2010-07-21 2015-07-30 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition
RU2013111961A (en) 2013-03-18 2014-09-27 Олег Ильич Эпштейн METHOD FOR DETERMINING THE EXPRESSION OF MODIFICATION ACTIVITY ASSOCIATED WITH A CARRIER
RU2013111962A (en) 2013-03-18 2014-09-27 Олег Ильич Эпштейн METHOD FOR DETERMINING THE EXPRESSION OF MODIFICATION ACTIVITY ASSOCIATED WITH A CARRIER
PH12018502667A1 (en) * 2013-10-23 2022-11-14 Gemvax And Kael Co Ltd Composition for treating and preventing benign prostatic hyperplasia
GB201513921D0 (en) * 2015-08-05 2015-09-23 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311897A (en) 1979-08-28 1982-01-19 Union Carbide Corporation Plasma arc torch and nozzle assembly
RU2181297C2 (en) * 2000-06-20 2002-04-20 Эпштейн Олег Ильич Method of treatment of pathological syndrome and medicinal agent
RU2197266C1 (en) * 2001-06-01 2003-01-27 Эпштейн Олег Ильич Medicinal agent and method of treatment of erosive and inflammatory diseases of gastroenteric tract
RU2001134982A (en) * 2001-12-26 2004-02-20 Олег Ильич Эпштейн METHOD OF IMMUNE RESPONSE CORRECTION AND MEDICINE
UA76641C2 (en) * 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Homeopathic medicinal agent and method for curing diseases of prostate
UA76639C2 (en) * 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Homeopathic medication and method for treating erectile dysfunctions
UA76638C2 (en) 2002-08-02 2006-08-15 Oleh Illich Epshtein Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon
TWI345470B (en) 2003-03-14 2011-07-21 Nutrition Res Inc Homeopathic formulations useful for treating pain and/or inflammation
ATE532416T1 (en) * 2004-09-03 2011-11-15 Chr Hansen As FERMENTED MILK PROTEINS WITH RECEPTOR LIGAND AND THEIR USES
BRPI0621588A2 (en) * 2006-04-04 2011-12-13 Dong A Pharm Co Ltd agent for the prevention and treatment of prostatic hyperplasia comprising the pyrazolpyrimidinone compound
CA2654408C (en) * 2006-06-06 2018-05-08 Oleg Iliich Epshtein Medicinal agent for treating fatness, diabetes, and diseases associated with impaired glucose tolerance
RU2438707C2 (en) * 2006-06-06 2012-01-10 Олег Ильич Эпштейн Medication for per oral treatment of diabetes mellitus and other diseases accompanied by disturbance of tolerance to glucose, and method of obtaining hard drug form for per oral therapy of diabetes mellitus and other diseases, accompanied by disturbance of tolerance to glucose
JP2009542800A (en) * 2006-07-13 2009-12-03 マゼンス インコーポレイテッド Compositions containing metal-acidic amino acid chelates that promote metal absorption
JP2013532181A (en) * 2010-07-15 2013-08-15 イリイチ・エプシテイン オレグ Combination pharmaceutical composition and method for treating functional diseases or conditions of the gastrointestinal tract
DE112011102349T5 (en) * 2010-07-15 2013-04-18 Oleg Iliich Epshtein Pharmaceutical composition and method of treatment
CZ2013105A3 (en) * 2010-07-15 2013-05-22 Iliich Epshtein@Oleg Method of increasing effect of antibody activated potentiated form

Also Published As

Publication number Publication date
EA029860B1 (en) 2018-05-31
AU2011278042B2 (en) 2017-02-16
ES2425314A2 (en) 2013-10-14
JP2016199570A (en) 2016-12-01
AU2011278042A1 (en) 2013-03-07
SG187036A1 (en) 2013-02-28
ITTO20110631A1 (en) 2012-01-16
US20130064860A1 (en) 2013-03-14
GB201302651D0 (en) 2013-04-03
WO2012007849A2 (en) 2012-01-19
CN103282384A (en) 2013-09-04
EA201300129A1 (en) 2013-12-30
EP2593483A2 (en) 2013-05-22
MX354187B (en) 2018-02-16
ES2425314R1 (en) 2014-07-09
GB2495885A (en) 2013-04-24
CA2805094A1 (en) 2012-01-19
GB2495885B (en) 2017-11-22
MX2013000547A (en) 2014-04-14
MY165267A (en) 2018-03-15
DE112011102350T5 (en) 2013-04-18
JP2013538791A (en) 2013-10-17
JP2018150322A (en) 2018-09-27
FR2962655A1 (en) 2012-01-20
WO2012007849A3 (en) 2012-04-05
NZ606775A (en) 2015-08-28

Similar Documents

Publication Publication Date Title
GB2495885B (en) Combination pharmaceutical composition and methods of treating genitourinary system disorders
EP2552433A4 (en) Compositions and methods for the treatment of somatosensory disorders
EP2603202A4 (en) Compositions and methods for treatment of taupathy
IL226401A0 (en) Methods of treating fgf21-associated disorders
HUE041553T2 (en) Methods and compositions for the treatment of monogenic diseases
EP2655334A4 (en) Compositions and methods useful for treating diseases
IL225471A0 (en) Compositions and methods for the prevention and treatment of cancer
GB201302652D0 (en) Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases
IL225239A0 (en) Compositions for the treatment of acne and related disorders
EP2771030A4 (en) Compositions and methods for treatment of proteinopathies
DK3292875T3 (en) Compositions and methods for treating diseases
GB201302653D0 (en) Pharmaceutical compositions and methods of treatment
GB2548034B (en) Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
ZA201408055B (en) Compositions and methods for the treatment of local pain
IL233639A0 (en) Compositions and methods for the treatment of hepatic diseases and disorders
EP2590674A4 (en) Compositions and methods for treating influenza
EP2847158A4 (en) Compositions and methods for treatment of neuromuscular disorders and neurodegenerative disorders
IL238126B (en) Formulations for the treatment and prevention of obesity
ZA201408060B (en) Compositions and methods for the treatment of neurological disorders
ZA201408062B (en) Compositions and methods for the treatment of multiple sclerosis
EP2934501A4 (en) Uses and methods for the treatment of liver diseases or conditions
ZA201408061B (en) Compositions and methods for the treatment of neurological disorders
ZA201408058B (en) Compositions and methods for the treatment of epilepsy
EP2578206A4 (en) Pharmaceutical composition for the treatment of disorders of the lower section of the urogenital system
AU2010902219A0 (en) Compositions and methods for treating neurodegenerative disorders